LP247820-6EravacyclineActive
Description
LP247820-6 Eravacycline
Eravacycline is a synthetic tetracycline antibiotic that is structurally similar to tigecycline and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It is a broad-spectrum antibiotic that can be administered both orally and intravenously. It is effective against gram-positive, gram-negative and anaerobic bacteria, except for Pseudomonas aeruginosa. As of early 2017, eravacycline is being studied in phase 3 clinical trials. [PMID:26863149]
Source: Regenstrief LOINC
Basic Part Properties
- Name
- Eravacycline
- Type
- Component
- Created On
- 2017-01-12
- Construct for LOINC Short Name
- Eravacycline
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP247820-6
Language Variants Get Info
- zh-CNChinese (China)
- 厄伐环素
Synonyms: Eravacycline;厄拉伐环素; 艾拉环素; 艾拉伐环素; TP-434; CAS 1207283-85-9; synthetic fluorocycline antibiotic; 合成类含氟四环素类衍生物类抗生素; 新型四环素类广谱抗菌药物 - nl-NLDutch (Netherlands)
- eravacycline
- it-ITItalian (Italy)
- Eravaciclina
- es-ESSpanish (Spain)
- Eravaciclina
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright